# Gemigliptin and Biomarkers of Kidney Injury and Vascular Calcification

> **NCT04705506** · NA · COMPLETED · sponsor: **Bangkok Metropolitan Administration Medical College and Vajira Hospital** · enrollment: 201 (actual)

## Conditions studied

- Diabetic Nephropathies

## Interventions

- **DRUG:** Gemigliptin

## Key facts

- **NCT ID:** NCT04705506
- **Lead sponsor:** Bangkok Metropolitan Administration Medical College and Vajira Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-05
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-03-01
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2021-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04705506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04705506, "Gemigliptin and Biomarkers of Kidney Injury and Vascular Calcification". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04705506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*